SC-046 is primarily utilized in the field of medical research, particularly in studies related to cardiovascular diseases. It functions as a potent and selective inhibitor of thromboxane synthase, an enzyme involved in the production of thromboxane A2, which plays a significant role in platelet aggregation and vasoconstriction. By inhibiting this enzyme, SC-046 helps in reducing the formation of blood clots, making it a valuable compound in the investigation of anti-thrombotic therapies. Researchers also explore its potential in managing conditions such as myocardial infarction, stroke, and other thrombotic disorders. Additionally, SC-046 is used in pharmacological studies to better understand the pathways and mechanisms associated with thromboxane A2 and its impact on vascular and platelet function.